Search

everythinglearnresearchcommunity

for

Search:↓

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Two cosmetic lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

RTA 408 cream protects mice from radiation skin damage.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Ixekizumab effectively treats generalized pustular psoriasis.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

MSC-CM cream speeds up burn wound healing better than the control treatment.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Ruby laser treatment is effective and well-tolerated for reducing hair growth.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.